GlassScriptPhysician profile
Steven M Kelly
NPI 1629086475
$35,149.84
in general payments reported to CMS, 2019-2025
14 companies · $148 in 2025
The $148 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $16K · 2020: $9,225 · 2021: $4,738 · 2022: $2,936 · 2023: $1,253 · 2024: $1,157 · 2025: $148.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,146 · Travel and Lodging: $913 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,145.50 |
| Travel and Lodging | $912.60 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $32,907.43 | 2019-2024 | Da Vinci Sp, Da Vinci Surgical System |
| Medtronic, INC. | $1,490.61 | 2023-2025 | Signia, Ligasure, Parietene Ds |
| Ethicon US, LLC | $321.88 | 2019-2023 | Enseal, Stratafix |
| Pacira Pharmaceuticals Incorporated | $127.82 | 2019 | |
| Conmed Corporation | $82.37 | 2019-2023 | Airseal |
| Becton, Dickinson and Company | $77.67 | 2024 | Phasix Mesh |
| Genentech USA, INC. | $27.13 | 2025 | Itovebi |
| Stryker Corporation | $22.85 | 2023 | 1788 |
| Celgene Corporation | $20.57 | 2019 | |
| Lilly USA, LLC | $19.90 | 2019 | |
| Novartis Pharmaceuticals Corporation | $15.66 | 2019 | |
| Merck Sharp & Dohme LLC | $13.62 | 2019 | |
| Davol INC. | $11.48 | 2020 | |
| Tesaro, INC. | $10.85 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Kelly listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.